Abstract
Many dangerous bacteria have become highly resistant to traditional antibiotics, which is a huge public health concern. This study investigated the use of silver nanoparticles biosynthesized in a culture filtrate of Lactobacillus acidophilus as antimicrobials. UV–visual spectrophotometry, Fourier-transform-infrared spectroscopy, X-ray power diffraction, and scanning electron microscopy have all validated the findings. The biosynthesized nanoparticles ranged in size from 33 to 90 nm. The cytotoxicity of the nanosilver generated was then investigated using nine 200 g BW rats separated into three groups. When compared to the control group, the treated rats showed little signs of toxicity; parameters of physiological function, including alanine transaminase, aspartate aminotransferase, albumin, creatinine, and urea were significantly different in treated and non-treated animals. Moreover, the antibacterial role of the generated silver nanoparticles was examined in multi-drug resistant (MDR) pathogenic bacteria, Proteus vulgaris, Escherichia coli, Staphylococcus aureus, and Klebsiella pneumoniae, revealing high antibacterial activity against the examined bacteria. For more demonstration of the effect of the nanosilver on transcription and gene regulation of treated and non-treated bacteria differential display droplet digital-PCR was used, and the results revealed that several genes were up- and down-regulated. Some genes were selected for DNA sequencing and according to the sequence analysis, these genes were mecA, beta-lactam, and unidentified protein genes, and these have been deposited in the GenBank Database with the following accession numbers: Staphylococcus MZ748472 and Klebsiella MZ748473. We conclude that silver nanoparticles biosynthesized by L. acidophilus are environmentally friendly and have antibacterial activities against MDR pathogenic bacteria.
Key Points
-
Our gifted results established that we were right for renewed interest of AgNPs.
-
The AgNPS, can be used to prevent treatment failure.
-
MDR bacteria are of a great health burden and should be overcomed.
Similar content being viewed by others
Introduction
The resistance of pathogenic bacteria to conventional antibiotics is a serious threat to health worldwide. Bacterial resistance to antibiotics is a major therapeutic problem (Levy 1992). Methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci multi-drug-resistant Mycobacterium tuberculosis (MDRTB) strains, and multi-drug-resistant (MDR) Gram-negative bacteria are frequently found. Some bacteria are inherently resistant to antibiotics, while others have acquired resistance to antibiotics once widely used to treat them, although no pharmaceutical intervention is devoid of problems associated with resistance (Nikaido 1998). When bacteria multiply in the presence of antibiotics, resistance develops along with a genetic mutation. The mutant gene can easily be passed on to other bacteria (Enright et al. 2002).
Developing a dependable, environmentally acceptable process for nanomaterial synthesis is a difficult task. L. acidophilus filtrate has been used as a reduction and capping agent in biosynthesis of silver nanoparticles (AgNPs) that have potential antimicrobial properties against Klebsiella pneumoniae (Rajesh et al. 2015). AgNPs thus created were examined in Gram-negative E. coli and Pseudomonas aeruginosa and it was shown that all antibiotic-resistant bacterial species are highly sensitive to silver nanoparticles biosynthesized by L. acidophilus (Cathrine et al. 2010). The development of nanoparticles with a variety of biologic properties is gaining popularity (Abdel-Azeem et al. 2020). Nanomaterials have unique structures with unique physical, chemical, and biological properties; as a result of their nanoscale size, nanomaterials have a wide range of applications (Stoimenov et al. 2002). Nanotechnology may be a useful tool for controlling a wide range of diseases, and this could be accomplished by delivering nanoparticles as functional molecules and/or diagnostic tools for specific diseases. Nanotechnology is also being assessed in agricultural diseases and food safety (Sharon et al. 2010). Antimicrobial nanoparticles could be utilized to fight a variety of infections (Wani et al. 2012). Because of their unusual features, AgNPs apart from their antibacterial and antifungal qualities have received much attention in recent years (Krzyzanowski et al. 2021).
Microorganisms are known to be very susceptible to Ag ions and Ag-based compounds. Bio-AgNPs were found to have significant biocidal effects on as many as 12 bacterial species, including E. coli (Chen and Schluesener 2008). Silver has traditionally been used to suppress bacterial growth in a number of settings, such as dental procedures and burn lesions (Catauro et al. 2004; Crabtree et al. 2003). AgNPs have been shown to be an effective biocide against a wide range of bacteria, including Gram-positive and Gram-negative bacteria (Jones and Hoek 2010). Many studies have emphasized AgNPs as a promising strategy for the synthesis of new antibacterial agents (Youssef and Elamawi 2018).
The tests that are performed on the liver; liver function tests; being misleading because many of the tests do not assess the liver’s function but rather identify the source of the damage. Hepatocellular disease is defined by elevated ALT and AST levels that are out of proportion to ALP and bilirubin. The ability of the liver to manufacture albumin and vitamin K-dependent clotting factors can be used to assess its real function (Ribeiro et al. 2019).
β-Lactam antibiotics, for example penicillin and methicillin, are among the most potent and oldest antibiotics that inhibit the formation of bacterial cell walls. Some bacteria produce the lactamase enzyme, which breaks down the β-lactam ring. Bacteria that express the mecA gene, which encodes low-binding-affinity penicillin-binding proteins, are another source of resistance; methicillin-resistant S. aureus (MRSA) have adapted this method as well (Rice 2012).
Materials and methods
Bacterial strains
All the bacterial strains involved in this study are brought from MIRCEN (Ain Shames University, Egypt): Staphylococcus aureus EMCC 1351, Escherichia coli ATCC 25922, Klebsiella pneumoniae EMCC 1637, Lactobacillus acidophilus EMCC 1324 and Proteus vulgaris ATCC 8427.
Preparation of L. acidophilus filtrate and silver nitrate reduction
The reduction of silver nitrate yielded bionanosilver with Lactobacillus acidophilus filtrate according to the method of Rajesh et al. (2015) as Silver nanoparticles were made using deionized water as a solvent. L. acidophilus starter culture was incubated in Man-Rogosa-Sharpe broth overnight at 37 °C for 48 h. Following incubation, the culture was centrifuged for 30 min at 10,000 rpm to separate the supernatant using Whatmann filter paper no. 1. After that, different ratios of 2:8, 3:7, and 4:6 of culture filtrate to silver nitrate (Sigma, Aldrich) solution were applied to the culture filtrate. The synthesis was then continued for 24 h at 35 °C in the dark. Silver nanoparticle isolation and purification Centrifugation was used to separate the silver nanoparticles and it took 20 min at 10,000 rpm. Two times, sterile distilled water was used to wash the pelleted silver nanoparticles.
Spectral study of UV–visible light
A UV–visible spectrophotometer set to 420 nm was used to track the biosynthesis of AgNPs on a regular basis; 0.1 mL of the sample was obtained and diluted to 2 mL with deionized water for the analysis (El-Aassar et al. 2020).
Pathogenic bacteria
Luria–Bertani (LB) broth media (Becton-Dickinson and Co., USA) were used to culture the bacteria (P. vulgaris, E. coli, S. aureus, and K. pneumoniae). One-mL aliquots of a 24-h-old broth culture of the tested microorganisms were aseptically disseminated onto nutrient agar slopes and incubated for 24 h at 37 °C. The bacterial growth was extracted and washed away with sterile normal saline, yielding a solution with roughly 108–109 CFU/mL. The suspension was kept refrigerated at 4 °C until it was used (Al-Askar et al. 2013).
Cytoxicological effects of bionanosilver on experimental animals
Nine rats about 200 g in weight were divided into three groups to study nanoparticle toxicity in vivo. The three groups were G1, intragastric application with 200 mg/kg AgNPs, sacrificed after 1 week; G2, animals given the same dose but kept for 2 weeks; and G3, the control animals (Lala et al. 2022).
Antibacterial activity of AgNPs
The antibacterial efficacy of the generated AgNPs against harmful bacteria was investigated according to the method of Al-Askar et al. (2013). In addition, biogenic antibiotics (200 µg/mL) such as ampicillin, gentamicin, and streptomycin were used to test the nanoparticles’ bactericidal activity.
Bionanosilver characterization using scanning electron microscopy
One drop of the created AgNPs aqueous suspension was put on a glass slide, and the films on the SEM grids were allowed to dry for 2 min. SEM analysis was carried out on a Hitachi-JP/H7600 apparatus (Japan) with a 100 kV accelerating voltage. With the use of SigmaScan Pro software, the size of the resulting AgNPs was determined based on SEM micrographs (SPSS Inc., Version 4.01.003). Energy dispersive X-ray studies were performed on a JEOL JSM-6400 microscope (Japan) (El-Aassar et al. 2020).
X-ray diffraction and fourier-transform-infrared spectroscopy
X-ray power diffraction (XRD) (Shimadzu XRD 7000 X-ray diffractometer, Japan) was used to explore the structure of the copolymer as well as the formation of AgNPs, and the structure of the AgNPs was evaluated using Fourier-transform-infrared (FTIR) spectra. To make pellets, powder samples were combined with potassium bromide. A Bruker TENSOR Series FTIR spectrometer (Germany) connected to a PC was used to record FTIR spectra in the absorbance mode, and the data were analyzed using IR Solution OPUS™ software (El-Aassar et al. 2020).
Analyzing particle size
A submicron particle size analyzer was used to examine the particle size of AgNPs during their formation (Beckman Coulter, USA). The sample was dispersed in water at 20 °C with a viscosity of 1.002 and a refractive index of 1.33 (El-Aassar et al. 2020).
Total RNA extraction and cDNA synthesis from treated and untreated bacteria
An RNeasy Mini Kit was used to isolate bacterial RNA from both treated and untreated bacteria, according to the manufacturer’s recommendations (Qiagen, Germany). The isolated RNA was treated with DNase for 1 h at 37 °C to eliminate any DNA residue. Reverse transcription of purified total RNA into cDNA was performed in a reaction volume of 25 µL. Included in the reaction mixture were 2.5 µL of 5× buffer with MgCl2, 2.5 µL of 2.5 mM dNTPs, 4 µL of oligo (dT) primer (20 pml/L), 2 g RNA, and 200 U reverse transcriptase enzyme (MLV, Fermentas, USA). A thermal cycler (Eppendorf, Germany) was used to perform RT-PCR amplification at 42 °C for 1 h and 72 °C for 10 min. The cDNA was then kept at − 20 °C until it was needed (El-Aassar et al. 2020).
PCR with differential display
The reverse primers of the mecA and beta-lactam genes were used to trace the mRNA of the two genes in the bacteria treated with biosynthesized nanosilver. For mecA, R: 5′-AGTGCAGTA CCGGATTTGC-3′ (Kumurya 2015). For beta-lactam, R: 5′-GAGCTCGGTATTGTAATATGATCCTCTAGA-3′ (Jiang et al. 2020). A total amount of 25 µL of the droplet-digital PCR (DD-PCR) reaction mixture was used according to Ramadan (2015). The PCR amplification was carried out in an Eppendorf thermal cycler, which was designed for one cycle at 95 °C for 5 min, followed by 34 cycles as follows: Denaturation at 30 s at 95 °C, annealing 1 min at 45–48 °C, and elongation at 1 min at 72 °C. As a last extension, the reaction was incubated at 72 °C for 10 min. Prior to loading 10 µL per gel slot, 2 µL of loading dye was applied. In 1.5% agarose/0.5× TBE gels, electrophoresis was done at 80 v using 0.5× TBE as running buffer, and the gel was subsequently stained in 0.5 µg/mL (w/v) ethidium bromide solutions and destained in deionized water. Finally, a gel documentation system was used to visualize and photograph the gel. The STATISTICA5 tool was used to evaluate the data based on the up-down-regulated genes.
Sequencing of selected bands and DNA sequence analysis
Four distinct bands (three down-regulated and one uncontrolled) were chosen and purified from the gel using a PCR purification kit (Qiagen, USA), and the purified DNA was sent to be sequenced (Macrogene, Korea). The sequence analysis was performed using the CLUSTALW program (https://www.genome.jp/tools-bin/clustalw) and the phylogeny was constructed using the MEGA 5 program (https://www.megasoftware.net/).
Analytical statistics
Collected data were processed then reported as mean plus or minus standard deviation (mean ± S.D.). Using Excel, one-way-ANOVA (Microsoft Office 2007) was performed to assess the effect of prepared AgNPs on various physiological parameters. A value of P < 0.05 was considered to be statistically significant.
Results
Silver nitrate reduction and nanosilver formation
The OD 420 increase began in the first 5 h, then reached its peak at 80 h, and then declined after 100 h of incubation (Fig. 1). After 10 days of incubation, the color of L. acidophilus filtrate shifted from yellow to dark brown.
SEM observations of AgNPs
The size of the biosynthesized AgNPs ranged from 33 to 90 nm, according to SEM observations (Fig. 2).
XRD and FTIR analysis
The crystalline nature of biosynthesized silver NPs was confirmed by XRD examination using L. acidophilus showing diffraction peaks at 2θ values at = 29.8 °C, 32.3 °C, 38.9 °C, and 44.7 °C. Silver crystal planes, respectively which are indexed as crystalline silver (Fig. 3), also Fig. 4 showed the FTIR spectra of biosynthesized silver nanoparticles. The number of functional biological groups responsible for the reduction of Ag ions, which act as capping or stabilizing agents, was discovered through spectral analysis utilizing FTIR. Absorbance bands of L. acidophilus with Ag ions observed at 3425.60/cm were assigned to O–H (s) groups, 1647.26/cm assigned to carboxylic group (OHC=O), and 2935.75/cm assigned to alkyl group (–CH3). These peaks in the FTIR spectra show that L. acidophilus molecules with OH and CO groups play an important role in the reduction and stability of NPs.
Cytoxicological impacts of synthesized bionanosilver
When analyzing several physiological indicators, the L. acidophilus nanoparticles had little harmful effect on the treated rats when compared to the control non-treated group. The parameters investigated were ALT, AST, creatinine, albumin, and urea (Table 1) as followed:
Impacts of AgNPs administration on AST and ALT
The impact of utilization of AgNPs on levels of AST and ALT, respectively declared that there was a significant increase of serum AST level in 200 mg/kg AgNPs groups treated for 14 days (324.62 ± 0.015) and 7 days (235.14 ± 0.025), respectively, compared to the control groups (115.76 ± 0.01) and (115.74 ± 0.015) at 14 and 7 days, respectively, also there was a significant increase of serum ALT level in 200 mg/kg AgNPs groups treated for 14 days (71.21 ± 0.0153) and 7 days (48.65 ± 0.01), respectively, compared to the control group (27.1 ± 0.02) and (27.13 ± 0.01) at 7 and 14 days respectively.
Impacts of AgNPs administration on serum albumin
There was a considerable drop in albumin levels throughout the group treated with 200 mg/kg AgNPs for 7 days (0.38 ± 0.015) and 14 days (0.17 ± 0.01), respectively, compared to the control groups (0.95 ± 0.015) and (0.95 ± 0.02) at 7 and 14 days respectively.
Impacts of AgNPs administration on serum creatinine and urea
Serum levels of creatinine and urea were showed a significant increase in 200 mg/kg AgNPs treated rats. Creatinine levels in the blood increased significantly in groups treated for 14 days (1.65 ± 0.01) and 7 days (1.17 ± 0.021), respectively, compared to the control group (0.38 ± 0.01) and (0.367 ± 0.015) at 7 and 14 days, respectively. Serum urea levels showed a significant increase in treated animals (53.9 ± 0.01) and (38.29 ± 0.015) after 14 and 7 days, respectively, as compared to control non-treated groups at 7 days (18.24 ± 0.015) and 7 days (18.21 ± 0.015).
Antibacterial activity of bionanosilver against four pathogenic bacterial strains compared with three commercial antibiotics
As shown in Table 2, the AgNPs formed with the filtrate of the L. acidophilus showed high activity against the four MDR bacteria when compared with the chemically synthesized antibiotics. The concentration of 25% showed high activity against the four pathogenic bacteria, and this activity was increased with the concentration of Ag used. The lowest inhibition zones obtained by the AgNPs were 5 mm (25 µg/mL) and the highest activity was obtained with 100% concentration (20 mm); in contrast the lowest activity obtained by the chemical antibiotics was 4 mm (200 µg/mL) and the highest activity was 10 mm (streptomycin). Collectively, the activity of the biosynthesized nanosilver was 200% greater as compared with the chemical antibiotics, and the four examined bacterial strains showed sensitivity with different manners.
DD-PCR
Data presented in Fig. 5 show that treated and non-treated bacteria have different DNA patterns. Primers mecA and beta-lactam genes scan the transcriptome of the treated cells when compared with non-treated ones. Several genes were found to be down-regulated, whereas others were activated at the same time. The most interesting thing is that all the amplified bands in the same bacterial species are polymorphic and there are no monomorphic bands. The species which are characterized by shutdown of the most amplicons are E. coli followed by P. vulgaris and S. aureus, but in case of K. pneumoniae, at least three genes are induced. The induced genes could be transcription factors such as zinc finger protein but the genes which are completely suppressed are mostly defense or DNA resistance genes such as mecA gene.
Up- and down-regulated genes
Impact of AgNPs on the transcriptomes in the treated bacteria compared to the untreated bacteria was clear, and it was based the suppressed and activated genes. In the case of P. vulgaris, two genes were suppressed, one approximately 820 bp and the second one about 270 bp. In E. coli, two genes were completely suppressed, one 820 bp (the same molecular size of that P. vulgaris) and the second one 540 bp. Accordingly, S. aureus had a gene about 300 bp that was completely suppressed and another gene about 250 bp was induced. Finally, in the case of K. pneumoniae, two genes were up-regulated (induced), one 540 bp and the second one 200 bp.
Sequencing and sequence analysis
The DNA sequence of the down-regulated gene isolated from control S. aureus, GenBank MZ748472-MZ748473, was identified as mecA. When the sequence of the mecA gene of the S. aureus (Egyptian isolate) was compared with other mecA genes listed in GenBank (Fig. 6), it was observed that gene is closely related to the gene S. aureus MZ2359758 isolate (Baghdad, Iraq). In the case of the zinc finger protein (Fig. 7), it is clear the genes isolated from Odontomachus brunneus in Florida (USA) and the Egyptian one are highly similar.
Phylogentic tree for the isolated upregulated Zinc finger protein gene isolated from K. pneumonia compared with other Zinc finger protein genes listed on Gene Bank. A Phylogeny constructed based on the DNA nucleotide sequence. B Phylogeny constructed based on the deduced amino acids of the obtained DNA sequence
Discussion
Silver nitrate reduction and nanosilver formation was in accordance with Abdel-Azeem et al. (2020) who proved that the color shift in the reaction mixture confirmed the production of the AgNPs. And size of the biosynthesized AgNPs which ranged from 33 to 90 nm by SEM was nearly in the same rang obtained by El-Aassar (2013), who found that the prepared AgNPs size ranged between 50 and 80 nm while higher than what El-Deeb et al. (2015) found when they produced AgNPs with sizes ranging from 20 to 60 nm and may be attributed to the method and source of synthesis of AgNPs. About XRD and FTIR analysis of biosynthesized silver NPs was an accurate method for characterization of AgNPs as reported by Abdel-Azeem (2020) also agreed with the findings of El-Sherbiny et al. (2016) and Yusof et al. (2020), who used FTIR to characterize synthesized AgNPs.
Lactobacillus acidophilus nanoparticles had little harmful effect on the treated rats when compared to the control non-treated group. The physiological parameters investigated were ALT, AST, creatinine, albumin, and urea (Table 1) as well as Fig. 5A–E, this was in accordance with Lee et al. (2010) who reported that AgNPs exposure changed the expression of many genes linked to motor neuron problems, neurodegenerative illness, and immune cell function, indicating possible neurotoxicity and immunotoxicity from contact with AgNPs. However, Stebounova et al. (2011) reported that after 10 days of AgNP treatment, mice showed no signs of lung inflammation or cytotoxicity. This may be attributed to the nature and source for biosynthesis of AgNPs.
Antibacterial activity of bionanosilver against four pathogenic bacterial strains compared with three commercial antibiotics was obvious as shown in Table 2, when Manzoor et al. (2016) treated E. coli cells with ZnO, they got the same findings. AgNPs are powerful antimicrobials that kill a wide range of Gram-negative and Gram-positive MDR bacteria (Burrell et al. 1999; Yin et al. 1999) (Percival et al. 2007). Li et al. (2009) showed that AgNPs are being investigated as a valuable material because of their potent antibacterial properties. To study the antibacterial activity of Ag/porous poly(l-lactic acid fibrous membranes, antibacterial tests were performed using E. coli and Staphylococcus, two bacteria that commonly invade wounds and other tissues, and good results were obtained (Yeo et al. 2003). This agrees with studies published showing that AgNPs bind to the negatively charged bacterial cell wall, rupturing it, and causing cell death via denaturation of cell protein (Lin et al. 1998, Zawrah et al. 2011). According to recent findings, silver nanoparticles interact with bacterial cells in a shape-dependent manner (Pal et al. 2007).
As shown in Fig. 5, treated and non-treated bacteria have different DNA patterns, Pillai et al. (2014) investigated the effects of nanosilver on the transcriptome, proteome, and phenotypic of Chlamydomonas reinhardtii. They found that microalgae cells treated with nanosilver responded positively, as evidenced by their transcriptome and proteome. Both the genome-wide transcriptome and proteome of microorganisms treated with nanosilver changed, according to Ankley et al. (2010), and these alterations should aid in determining the molecular pathways resulting from nanosilver stress. Furthermore, nanosilver has been shown to suppress RNA polymerase activity and RNA transcription in treated cells (Wang et al. 2013).
Interestingly, similarity in the isolated genes and the others listed in GenBank was obtained when their amino acids were compared. These results indicate that these genes may be different in nucleotide structure but similar in amino acid structure. It is well known the mecA is one of the DNA resistance genes that enable S. aureus to resist the many antibiotics. Similarly, the zinc finger protein is considered as the most common transcription factor in bacterial lineages, and it has a multiple functions as virulence, symbiosis, and/or cell cycle transcription. So AgNPs biosynthesized with L. acidophilus are environmentally friendly, fast-acting, and economical. They have antibacterial properties against some MDR Gram-positive and Gram-negative pathogenic microorganisms and may become more widely used in treatment and control of serious diseases caused by them.
Availability of data and materials
All data generated or analyzed during this study are included in the submitted manuscript.
References
Abdel-Azeem A, Nada AA, O’Donovan A, Thakur VK, Elkelish A (2020) Mycogenic silver nanoparticles from endophytic Trichoderma atroviride with antimicrobial activity. J Renew Mater 8:171–185. https://doi.org/10.32604/jrm.2020.08960
Al-Askar AA, Hafez EE, Kabeil SA, Meghad A (2013) Bioproduction of silver-nano particles by Fusarium oxysporum and their antimicrobial activity against some plant pathogenic bacteria and fungi. Life Sci J 10:2470–2475
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741
Burrell R, Wright JB, Heggers JP, Davis GJ (1999) Efficacy of silver-coated dressings as bacterial barriers in a rodent burn sepsis model. Wounds 11:64–71
Catauro M, Raucci MG, De Gaetano FD, Marotta A (2004) Antibacterial and bioactive silver-containing Na2O x CaO x 2SiO2 glass prepared by sol–gel method. J Mater Sci Mater Med 15:831–837. https://doi.org/10.1023/b:jmsm.0000032825.51052.00
Cathrine R, Ragunathan CR, Kumar KP (2010) Biosynthesis of silver nano particles using L. acidophilus (probiotic bacteria) and its application. Internat J Nanotechnol Appl 4:217–222
Chen X, Schluesener HJ (2008) Nanosilver: a nanoproduct in medical application. Toxicol Lett 176:1–12. https://doi.org/10.1016/j.toxlet.2007.10.004
Crabtree JH, Burchette RJ, Siddiqi RA, Huen IT, Handott LL, Fishman A (2003) The efficacy of silver-ion implanted catheters in reducing peritoneal dialysis-related infections. PDI 23:368–374. https://doi.org/10.1186/2047-2994-4-S1-P196
El-Aassar MR (2013) Functionalized electro spun nanofibers from poly (AN-co-MMA) for enzyme immobilization. J Mol Catal B: Enzym 85:141–148
El-Aassar MR, Ibrahim OM, Fouda MMG, Fakhry H, Ajarem J, Maodaa SN, Allam AA, Hafez EE (2020) Wound dressing of chitosan-based-crosslinked gelatin/polyvinyl pyrrolidone embedded silver nanoparticles, for targeting multidrug resistance microbes. Carbohydr Polym 255:117484. https://doi.org/10.1016/j.carbpol.2020.117484
El-Deeb NM, El-Sherbiny IM, El-Aassara MR, Hafez EE (2015) Novel trend in colon cancer therapy using silver nanoparticles synthesized by honey bee. J Nanomed Nanotechnol 6:2. https://doi.org/10.4172/2157-7439.1000265
El-Sherbiny IM, Salih E, Yassin AM, Hafez EE (2016) Newly developed chitosan-silver hybrid nanoparticles: biosafety and apoptosis induction in HepG2 cells. J Nanopart Res 18:172. https://doi.org/10.1007/s11051-016-3477-z
Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, Spratt BG (2002) The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). PNAS 99:7687–7692. https://doi.org/10.1073/pnas.122108599
Jiang W, Yang W, Zhao X, Wang N, Ren H (2020) Klebsiella pneumoniae presents antimicrobial drug resistance for βlactam through the ESBL/PBP signaling pathway. Exp Ther Med 19:2449–2456. https://doi.org/10.3892/etm.2020.8498
Jones CM, Hoek EMV (2010) A review of antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–1551. https://doi.org/10.1007/s11051-010-9900-y
Krzyzanowski D, Kruszewski M, Grzelak A (2021) Differential action of silver nanoparticles on ABCB1 (MDR1) and ABCC1 (MRP1) activity in mammalian cell lines. Mater 14:3383. https://doi.org/10.3390/ma14123383
Kumurya AS (2015) One step PCR for detection of Staphylococcus aureus specific sequence gene and mecA gene in Northwestern Nigerian hospitals. Antimicrob Resist Infect Control 4(Suppl 1):196
Lala V, Zubair M, Minter DA (2022) Liver function tests. StatPearls Publishing, Treasure Island
Lee HY, Choi YJ, Jung EJ, Yin HQ, Kwon JT, Kim JE, Im HT, Cho MH, Kim JH, Kim HY, Lee BH (2010) Genomics-based screening of differentially expressed genes in the brains of mice exposed to silver nanoparticles via inhalation. J Nanopart Res 12:1567–1578. https://doi.org/10.1007/s11051-009-9666-2
Levy SB (1992) The antibiotic paradox. How miracle drugs are destroying the miracle. Springer Science + Business Media, LLC, Berlin. https://doi.org/10.1007/978-1-4899-6042-9
Li L, Li Y, Li J, Yao L, Mak AF, Ko F, Qin L (2009) Antibacterial properties of nanosilver PLLA fibrous membranes. J Nanomater. https://doi.org/10.1155/2009/168041
Lin YE, Vidic RD, Stout JE, McCartney CA, Yu VL (1998) Inactivation of Mycobacterium avium by copper and silver ions. Water Res 32:1997–2000. https://doi.org/10.1016/S0043-1354(97)00460-0
Manzoor U, Siddique S, Ahmed R, Noreen Z, Bokhari H, Ahmad I (2016) Antibacterial, structural and optical characterization of mechano-chemical prepared ZnO nanoparticles. PLoS ONE 11:5. https://doi.org/10.1371/journal.pone.0154704
Nikaido H (1998) Multiple antibiotic resistance and efflux. Curr Opin Microbiol 1:516–523. https://doi.org/10.1016/s1369-5274(98)80083-0
Pal S, Tak YK, Song JM (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. Appl Environ Microbiol 73:1712–1720. https://doi.org/10.1128/AEM.02218-06
Percival SL, Bowler PG, Dolman J (2007) Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J 4:186–191. https://doi.org/10.1111/j.1742-481X.2007.00296.x
Pillai S, Behra R, Nestler H, Suter MJ, Sigg L, Schirmer K (2014) Linking toxicity and adaptive responses across the transcriptome, proteome, and phenotype of Chlamydomonas reinhardtii exposed to silver. PNAS 111:3490–3495
Rajesh S, Dharanishanthi V, Kanna AV (2015) Antibacterial mechanism of biogenic silver nanoparticles of Lactobacillus acidophilus. J Exp Nanosci 10:1143–1152. https://doi.org/10.1080/17458080.2014.985750
Ribeiro AJS, Yang X, Patel V, Madabushi VR, Strauss DG (2019) Liver microphysiological systems for predicting and evaluating drug effects. Clin Pharmacol Ther 106:139–147. https://doi.org/10.1002/cpt.1458
Rice LB (2012) Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones. Mayo Clin Proc 87:198–208. https://doi.org/10.1016/j.mayocp.2011.12.003
Sharon M, Choudhary AK, Kumar R (2010) Nanotechnology in agricultural diseases and food safety. J Phytol 2:83–92
Stebounova LV, Adamcakova-dodd A, Kim JS, Park H, O’Shaughnessy PT, Grassian VH, Thorne PS (2011) Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Part Fibre Toxicol 8:5. https://doi.org/10.1186/1743-8977-8-5
Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ (2002) Metal oxide nanoparticles as bactericidal agents. Langmuir 18:6679–6686. https://doi.org/10.1021/la0202374
Wang Z, Liu SJ, Ma J, Qu G, Wang X, Yu S, He J, Liu J, Xia T, Jiang GB (2013) Silver nanoparticles induced RNA polymerase-silver binding and RNA transcription inhibition in erythroid progenitor cells. ACS Nano 7:4171–4186. https://doi.org/10.1021/nn400594s
Wani SP, Dixin Y, Li Z, Dar WD, Chander G (2012) Enhancing agricultural productivity and rural incomes through sustainable use of natural resources in the semi-arid tropics. J Sci Food Agric 92:1054–1063. https://doi.org/10.1002/jsfa.4721
Yeo SY, Lee HJ, Jeong SH (2003) Preparation of nanocomposite fibers for permanent antibacterial effect. J Mater Sci 38:2143–2147. https://doi.org/10.1023/A:1023767828656
Yin HQ, Langford R, Burrell RE (1999) Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil 20:195–200. https://doi.org/10.1097/00004630-199905000-00006
Youssef MS, Elamawi RM (2018) Evaluation of phytotoxicity, cytotoxicity, and genotoxicity of ZnO nanoparticles in Vicia faba. Environ Sci Pollut Res 103:143701. https://doi.org/10.1007/s11356-018-3250-1
Yusof HM, Rahman A, Mohamad NR, Zaidan UH (2020) Microbial mediated synthesis of silver nanoparticles by Lactobacillus plantarum TA4 and its antibacterial and antioxidant activity. Appl Sci 10:6973. https://doi.org/10.3390/app10196973
Zawrah M, El-Moez A (2011) Antimicrobial activities of gold nanoparticles against major food-borne pathogens. Life Sci J 8(4):37–44
Acknowledgements
The authors extend their appreciation to the Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research through the project number IFP-IMSIU-2023040. The authors also appreciate the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) for supporting and supervising this project.”
Funding
Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia for funding this research through the project number IFP-IMSIU-2023040.
Author information
Authors and Affiliations
Contributions
EK, and EH contributed equally to the study’s conceptualization and design and participated in the application of classical microbiological techniques. EK, MR, NM, RS and EH followed the PCR assays, sequencing approaches, and sequence analysis. EK, MR, NM, RS and EH conceived the study and participated in the design. The first draft of the manuscript was written by EK, MR, NM, RS and EH. All authors critically evaluated the work for vital intellectual content and gave final approval to the published version.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The present work was ethically approved by Institutional Animal Care and Use Committees at the Pharmaceutical & Fermentation Industries Development Center of the General Authority of the City of Scientific Research and Technology Applications (SRTA-City) IACUCs #36-5E-0821, Egypt.
Consent for publication
All authors agree to publish.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Khalifa, E., Abdel Rafea, M., Mustapha, N. et al. Silver nanoparticles synthesized by probiotic bacteria and antibacterial role in resistant bacteria. AMB Expr 13, 140 (2023). https://doi.org/10.1186/s13568-023-01651-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13568-023-01651-7